Patents by Inventor Christopher J. Endres

Christopher J. Endres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING BREAST CANCER WITH TUCATINIB
    Publication number: 20220193076
    Abstract: The invention provides tucatinib and its use in methods of treating cancer, such as breast cancer. The invention also provides compositions and kits comprising tucatinib for use in treating cancer, such as breast cancer.
    Type: Application
    Filed: January 24, 2020
    Publication date: June 23, 2022
    Inventors: Luke WALKER, Christopher J. ENDRES, Anthony Jaeyong LEE, Hao SUN, Ariel R. TOPLETZ-ERICKSON
  • IL-17 receptor antibody formulation
    Patent number: 8883151
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Grant
    Filed: January 12, 2011
    Date of Patent: November 11, 2014
    Assignee: Kirin-Amgen, Inc.
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher J. Endres
  • ANTIBODY FORMULATION AND THERAPEUTIC REGIMENS
    Publication number: 20130022621
    Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
    Type: Application
    Filed: January 12, 2011
    Publication date: January 24, 2013
    Applicant: AMGEN INC
    Inventors: Dingjiang Liu, Holly Zhuohong Huang, David Andrew Martin, Christopher Boyd Russell, David H. Salinger, Scott Walter Baumgartner, Christopher J. Endres